Brain tumor embolization

Brain tumor embolization in Turkey: what is it and how does it work?

Brain tumor embolization is a minimally invasive endovascular procedure designed to cut off or substantially reduce the arterial blood supply feeding an intracranial tumour. Performed by interventional neuroradiologists in advanced neuro-angiography suites, the technique involves introducing a tiny, flexible microcatheter into an artery in the groin or wrist. Under continuous biplane fluoroscopic X-ray guidance, the specialist navigates the catheter through the arterial network directly into the selective microvessels supplying the tumour. Embolic agents—such as microscopic polymer beads, polyvinyl alcohol particles, biocompatible liquid embolic agents, or miniature platinum microcoils—are then infused to occlude these vessels, depriving the abnormal growth of oxygenated blood.

In modern neurosurgical practice, endovascular embolization is primarily performed as an adjunctive, preoperative step 24 to 72 hours before planned surgical craniotomy. By shutting down vascular channels prior to surgical resection, surgeons encounter substantially less intraoperative bleeding, operate within a clearer surgical field, and can resect fibrous tumours more safely. In select palliative cases where open skull surgery is contraindicated, embolization may also be used to alleviate intractable pain, reduce elevated intracranial pressure, or manage neurological deficits caused by mass effect. Specialised centres providing neurosurgery treatments in Turkey routinely combine neuro-interventional radiology with microsurgical resection teams to manage complex vascular skull base and intracranial masses.

Get my free quote

Does brain tumor embolization work and what does clinical evidence show?

Clinical evidence demonstrates that preoperative embolization is highly effective for its intended medical purpose: devascularizing target lesions, reducing surgical blood loss, and shortening operative duration. Peer-reviewed neurosurgical literature and clinical registries show that successful devascularization of vascular extra-axial tumours can decrease intraoperative blood transfusion requirements and lower the rate of perioperative complications. In tough, fibrous lesions such as meningiomas, blocking the central arterial pedicle causes ischaemic necrosis and softening of the core tissue, which allows the neurosurgeon to debulk and dissect the tumour away from adherent cranial nerves and cerebral parenchyma with greater precision.

However, an honest appraisal of the scientific evidence also highlights distinct limitations. Brain tumor embolization is almost never a standalone curative treatment. While embolic agents starve tumour cells, collateral arterial pathways frequently recruit or reopen over subsequent weeks if the lesion is not promptly resected. Furthermore, embolization does not replace standard radiation therapy or chemotherapy in malignant intra-axial tumours such as glioblastomas, where tumour cells infiltratively invade surrounding functional brain parenchyma along non-target cerebral vessels. International guidelines from neurosurgical societies emphasise that embolization should be reserved for cases where the procedural benefit of devascularization demonstrably outweighs the potential neuro-endovascular risks.

Which types of intracranial tumors can be treated with embolization?

Endovascular embolization is indicated primarily for hypervascular intracranial and skull-base tumours that receive their dominant arterial feeding vessels from branches of the external carotid artery, dural meningeal branches, or accessible branches of the internal carotid and vertebral systems. Common conditions evaluated for preoperative embolization include:

• Meningiomas: Particularly large skull base, convexity, sphenoid wing, or parasagittal meningiomas that have developed substantial arterial recruitment from the middle meningeal or ascending pharyngeal arteries.
• Skull base paragangliomas and glomus tumours: Highly vascular benign lesions, such as glomus jugulare and glomus vagale tumours, which bleed profusely during direct surgical exposure without prior devascularization.
• Hemangiopericytomas and solitary fibrous tumours: Vascular neoplasms that exhibit dense capillary networks requiring preoperative flow reduction.
• Hypervascular brain metastases: Particularly metastatic lesions originating from renal cell carcinoma, thyroid carcinoma, or choriocarcinoma, which frequently present with intense vascularity.
• Juvenile nasopharyngeal angiofibromas: Vascular tumours extending toward the cranial base in adolescent patients.

Conversely, intra-axial tumours like low-grade gliomas, diffuse astrocytomas, and acoustic neuromas (vestibular schwannomas) are rarely treated with embolization, because their vascular supplies are intimately intertwined with normal cerebral perfusion or internal auditory arteries where vessel occlusion carries unacceptable stroke risks.

Brain tumor embolization cost in Turkey compared with the UK, US and Germany

The overall brain tumor embolization cost varies according to the anatomical complexity of the arterial supply, the number of selective vessels requiring occlusion, the volume and type of embolic materials (such as specialised liquid embolic agents), whether general anaesthesia is required, and the duration of intensive care unit monitoring. The table below presents broad, approximate cost ranges for the endovascular embolization procedure alone across major medical destinations. These ranges represent general cross-border price benchmarks and do not include the cost of subsequent open surgical craniotomy or prolonged oncological hospitalisation.

When evaluating the total brain tumor embolization price, international patients can request a free quote with a comprehensive breakdown. In Turkish medical centres, an endovascular package typically includes pre-procedural blood work, diagnostic biplane cerebral angiography, the interventional neuroradiology theatre fees, catheterisation consumables and embolic substances, anaesthesiologist attendance, 24 hours of neurological intensive care monitoring, and subsequent ward accommodation. Factors that can alter the final price include unforeseen vascular tortuosity requiring additional microcatheters, post-procedure management of contrast reactions, or combined scheduling with a formal skull-base craniotomy.

Get my free quote

Embolization compared with direct resection and radiosurgery

Selecting the appropriate clinical pathway depends on tumor histology, size, vascular anatomy, patient age, and baseline neurological status. In many treatment algorithms, embolization acts as an adjunct rather than an alternative to surgical removal or focused radiation.

For pituitary lesions and selected midline skull base growths that breach the sellar floor, neurosurgical teams often evaluate whether a patient is a candidate for transnasal resection of tumor rather than open craniotomy or arterial embolization. Exploring the broad landscape of neurosurgery treatments in Turkey helps patients and their families understand how multiple modalities work together to optimize clinical outcomes.

Who is an appropriate candidate for endovascular tumor embolization?

A multidisciplinary neuro-oncology team decides whether to perform brain tumor embolization after evaluating cross-sectional magnetic resonance imaging (MRI), computed tomography (CT) perfusion studies, and diagnostic digital subtraction angiography. A suitable candidate generally presents with:

• A confirmed or strongly suspected hypervascular tumour where anticipated surgical blood loss exceeds safe thresholds.
• Tumour arterial feeders derived predominantly from accessible external carotid branches or non-critical meningeal vessels that can be super-selectively cannulated.
• Stable renal function sufficient to clear iodinated intravenous contrast agents.
• Safe coagulation parameters and adequate physiological resilience to undergo endovascular catheterisation followed promptly by surgical resection.

Conversely, patients who are not suitable candidates include individuals with tumours fed directly by terminal branches supplying eloquent cerebral cortex, motor pathways, or the ophthalmic artery, where embolic reflux could induce profound vision loss or ischaemic stroke. Severe contrast allergies, end-stage kidney failure, unmanageable coagulopathy, and extreme tortuosity or severe atherosclerotic disease of the aortic arch and carotid arteries represent serious contraindications that may prompt the team to proceed directly with open surgery without embolization.

The embolization procedure step by step: what happens during treatment?

Understanding the clinical sequence of brain tumor embolization helps alleviate patient anxiety. The procedure is carried out in an advanced neuro-interventional catheterisation lab under strict sterile conditions:

1. Preparation and anaesthesia: Most patients receive general anaesthesia to ensure complete immobility during high-resolution micro-imaging, although selective procedures may occasionally use conscious sedation with local anaesthesia at the puncture site.
2. Arterial access: The interventionalist punctures the common femoral artery in the groin or the radial artery at the wrist, inserting a vascular sheath.
3. Diagnostic roadmapping: A guide catheter is advanced into the carotid or vertebral circulation, and digital subtraction angiography maps the precise architecture of tumor-feeding arteries and surrounding venous drainage in real time.
4. Superselective microcatheterization: A hair-thin microcatheter (often under 0.5 mm in diameter) is guided over a steerable micro-guidewire deep into the primary feeding pedicles of the tumour.
5. Provocative testing and embolization: In select complex cases, short-acting anaesthetics or sedatives are injected into the vessel while testing neurological function to ensure the artery does not supply critical brain tissue. Once confirmed safe, the chosen embolic agent (particles, liquid adhesive, or coils) is carefully delivered until blood flow stasis into the tumour occurs.
6. Post-embolization angiography and closure: Final angiograms document the degree of tumour devascularization and confirm that normal cerebral circulation remains fully patent. The catheter is withdrawn, and an automated vascular closure device or manual compression seals the puncture site.

The entire procedure typically takes between 90 minutes and three hours, depending on the number of feeding vessels requiring catheterisation.

Hospital stay in Turkey and brain tumor embolization recovery milestones

Because brain tumor embolization is almost always followed within one to three days by definitive open surgical resection, brain tumor embolization recovery planning encompasses two distinct clinical phases: immediate post-catheterization monitoring and post-craniotomy convalescence. When travelling for brain tumor embolization in Turkey, patients should plan for an overall hospital stay of roughly 7 to 10 days, followed by several days of local outpatient recovery before flying home.

Key recovery milestones include:

• Day 1 (Immediate post-procedure): The patient is transferred directly to the neuro-intensive care unit for continuous neurological monitoring, blood pressure control, and puncture site observation. Bed rest is maintained for four to six hours to prevent arterial access bleeding. Mild headaches, localized scalp tenderness, or low-grade fever due to aseptic tumour necrosis are common and managed with prescribed analgesics.
• Days 2 to 3 (Resection window): Most surgical teams schedule the open craniotomy or tumor resection within 24 to 72 hours of embolization to capitalise on maximum devascularization before collateral circulation can develop.
• Days 4 to 8 (Post-surgical ward recovery): Following surgical resection, the patient transitions from the intensive care unit to the general neurosurgery ward, gradually resuming oral diet and gentle mobilising under physical therapy supervision.
• Days 9 to 14 (Fitness to fly and discharge): Sutures or surgical clips are reviewed, follow-up neurological examinations and baseline post-operative imaging are completed, and the surgical team assesses fitness to fly. Patients must not board a flight until intracranial air has safely reabsorbed and the neurosurgeon provides written travel clearance.

Get my free quote

Potential risks, complications and neuro-interventional safety

Like any complex endovascular intervention inside the cranial circulation, brain tumor embolization carries potential risks that must be carefully balanced against the hazards of non-embolized open surgery. Authoritative neurosurgical bodies, such as the American Association of Neurological Surgeons and the European Society of Minimally Invasive Neurological Therapy, classify complications into procedure-related neurovascular events and systemic reactions.

Documented procedural risks include:

• Non-target embolization: Inadvertent reflux or migration of embolic particles into normal cerebral arteries supplying functional brain parenchyma, which can cause ischaemic stroke, limb weakness, speech impairment, or visual disturbances.
• Intracranial haemorrhage: Acute rupture of fragile tumor vessels, altered haemodynamics, or hemorrhagic transformation of ischemic tumor tissue, which may necessitate emergency decompression craniotomy.
• Cranial nerve deficits: Ischaemic injury to tiny arterial branches supplying the facial, trigeminal, or lower cranial nerves, particularly during embolization of skull-base glomus tumours or meningiomas.
• Access site complications: Groin or wrist haematoma, arterial pseudoaneurysm, or retroperitoneal bleeding at the vascular puncture site.
• Contrast-induced nephropathy and allergic reactions: Renal stress caused by intravenous iodinated contrast media, especially in patients with pre-existing borderline kidney function.
• Tumour swelling: Acute edema within the ischemic tumour causing transient worsening of headache or increased intracranial pressure before definitive surgery.

Accredited hospitals mitigate these hazards through continuous intraoperative neuro-monitoring, biplane flat-detector imaging, superselective catheterisation protocols, and immediate access to 24-hour neurosurgical emergency backup.

How to choose a neurosurgical centre in Turkey and clinical red flags

Undergoing a neuro-interventional procedure abroad requires rigorous vetting of hospital credentials and clinical infrastructure. International patients should seek tertiary neurosurgical hospitals that hold internationally recognized accreditations and feature dedicated neuro-interventional angiography suites alongside dedicated neurosurgical intensive care units. The lead interventionalist should be a certified interventional neuroradiologist or endovascular neurosurgeon with documented fellowship training and high-volume experience in intracranial skull-base embolization.

Clinical red flags to be aware of include:

• Clinics that promise complete tumour disappearance through embolization alone without discussing surgical resection or histological examination.
• Lack of an on-site neuro-intensive care unit or lack of immediate 24/7 neurosurgical operating theatre availability in the same hospital facility.
• Vague pricing structures that omit catheter consumables, intensive care stay, or anaesthesia costs from the quotation.
• Pressure to undergo immediate intervention without a formal multidisciplinary tumor board review of your diagnostic DICOM MRI and CT scans.
• Absence of structured post-discharge follow-up protocols or failure to coordinate with medical teams in your home country.

To understand the coordination stages involved in receiving medical care abroad, you can review how it works before submitting medical records, and submit your diagnostic imaging to request a free quote for a multidisciplinary clinical review.

Essential questions to ask your interventional neurosurgery team

Before agreeing to brain tumor embolization, patients and family members should discuss the procedure in detail with the medical team. Consider bringing the following questions to your initial consultation:

• What specific vascular supply feeds my tumour, and which arterial branches do you plan to embolize?
• What type of embolic material (liquid agent, particles, or microcoils) will be used, and why is it preferred for my lesion?
• What is your team's documented experience and complication rate with endovascular embolization of this specific tumor type?
• How many hours or days after embolization will the definitive surgical resection take place?
• What immediate neurological symptoms should I expect upon waking from the embolization?
• Is provocative functional testing planned prior to depositing permanent embolic agents?
• What emergency protocols and neurosurgical operating facilities are immediately accessible if non-target vessel occlusion or bleeding occurs?
• What does the written hospital quote cover, and what extra fees might arise if extended intensive care is required?
• When will it be safe for me to fly home after the combined embolization and surgical resection?

Get my free quote

Hospitals with Neurosurgery in Turkey

Academic Hospital

Üsküdar, Istanbul

MoHHealth Tourism Licence+2

Get Free Quote

Lokman Hekim Istanbul Hospital

Pendik, Istanbul

JCIMoH+2

Get Free Quote

View all

Frequently asked questions